Cover Image
市場調查報告書

健康、保健10大技術:2016年

Health & Wellness Top 10 Technologies 2016

出版商 Technical Insights (Frost & Sullivan) 商品編碼 357217
出版日期 內容資訊 英文 110 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
健康、保健10大技術:2016年 Health & Wellness Top 10 Technologies 2016
出版日期: 2016年04月29日 內容資訊: 英文 110 Pages
簡介

本報告針對影響健康、保健市場2016年的技術動向提供生技仿製藥、癌症篩檢、分子剪刀、次世代幹細胞、治療用抗體、3D支架、癌症免疫療法、高效能基因定序、經皮藥物遞輸、奈米醫療相關技術開發動向、市場現況與最新動向。

第1章 摘要整理

第2章 生技仿製藥

  • 生技仿製藥穩定的長期成長
  • 致力於生物製造能力
  • 生產工程與技術的需求十分複雜
  • 製藥公司對生技仿製藥業界具有影響力
  • 歐洲法規制ゎ開發業者ズシゲサ最パ便利
  • 歐洲ザゾ認可濟ノ生技仿製藥數ゎ最高ズ
  • 設定策略相關疑問

第3章 癌症篩檢

  • 癌症篩檢可早期發現早期治療
  • 美國革新癌症篩檢技術
  • 對液態切片的投資擴大
  • 次世代篩檢是主要的使能技術
  • 新的篩檢技術影響醫療價值鏈
  • 先進國家引進率高
  • 設定策略相關疑問

第4章 分子剪刀

  • 農業生技、人類治療、研究開發、產業應用都受到分子剪刀影響
  • 用於基因組編輯的核酸□具有影響各種技術的能力
  • 基因組編輯專利申請擴大
  • CRISPR的專利戰將影響基因組編輯市場
  • 基因組編輯創新產生風險資本高度連續融資
  • 主要應用在人類治療藥物
  • 北美與歐洲獨佔市場
  • 設定策略相關疑問

第5章 次世代幹細胞

  • 次世代幹細胞的成功需要相關人士之間完美的相互作用
  • 臨床實驗與幹細胞銀行服務帶動市場
  • 細胞重組改變了智慧財產環境
  • 強大的政府支援與國際合作促進機會
  • 次世代幹細胞技術影響各種等級的業界決策
  • 各地區邁向技術革新與商品化
  • 展開臨床的主要問題
  • 設定策略相關疑問

第6章 治療用抗體

  • 治療用抗體開拓精密醫療時代
  • 探索單株抗體最新進步
  • 前三大專利持有方擁有整體專利數量的3分之1
  • 民間投資人士與融資企業矚目抗體治療
  • 腫瘤免疫學成為抗體治療主要重點
  • 市場前所未見的競爭
  • 開立企業證實了臨床發展
  • 設定策略相關疑問

第7章 3D支架

  • 靠著3D支架3D細胞培養工具擴大
  • 美國專利申請帶動技術革新
  • 開發NIAMS的主要融資者
  • 3D支架機能特徵影響組織工程
  • 主要相關人士注目於產品的體外實驗應用
  • 歐洲的3D細胞培養系統引進率最高
  • 設定策略相關疑問

第8章 癌症免疫療法

  • 癌症免疫療法搭上PD-1浪潮
  • 歐洲與亞洲企業帶領技術革新
  • 現代療法帶動投資環境
  • 癌症免疫療法的目標多為免疫檢查點
  • 肺癌是癌症免疫療法的主要應用
  • 歐美帶動癌症免疫療法市場
  • 設定策略相關疑問

第9章 高效能基因定序(HTGS)

  • 開發低價平台讓HTGS進步
  • 中國帶動HTGS技術革新
  • HTGS相關融資活動的重點為癌症
  • 技術能力可用性加速篩檢技術革新
  • HTGS未來會更常用於診斷
  • 美國帶動HTGS市場
  • 設定策略相關疑問

第10章 經皮藥物遞輸

  • 經皮藥物遞輸系統技術發展
  • 主要技術革新促進醫療發展
  • 技術動向可藉由專利分析
  • 官方與民間雙方的強力承諾
  • 微針技術
  • 全球對病患的擔憂促進經皮藥物遞輸發展
  • 設定策略相關疑問

第11章 奈米醫療

  • 智慧奈米技術可能成為次世代保健方法
  • 奈米醫療臨床開發有600以上
  • 頂尖企業獨佔奈米治療開發線
  • 政府近20年來瞭解奈米醫療的可能性
  • 奈米醫療與奈米技術發展證實了技術綜效
  • 奈米治療法從奈米構造到精密治療
  • 商業模式的變化
  • 大型製藥公司製品上市
  • 設定策略相關疑問

第12章 關於Frost & Sullivan

目錄
Product Code: D6F8-01-00-00-00

Top technology trends that are likely to have an impact in 2016

This strategic research service, Health & Wellness Top 10 Technologies, depicts the current landscape and the new trends in a series of developments associated with innovations in biosimilars, cancer screening, molecular scissors, next generation stem cells, three-dimensional (3D) scaffolds, therapeutic antibodies, cancer immunotherapy, high throughput gene sequencing (HTGS), transdermal drug delivery, and nanomedicine.

Techvision's professionals have monitored, gathered, and analyzed numerous emerging and disruptive technologies selecting this top 10 technologies, by contacting an extensive network of innovators, technology developers, financial institutions, technologists and researchers, among other players in the ecosystem, with the aim to provide your company or institution with a notable intelligence work that can help you build and implement strong growth strategies by leverage disruptive technologies and emerging innovations.

Table of Contents

1. EXECUTIVE SUMMARY

  • Research Scope and Index
  • Research Methodology
  • Assessment of Top Technologies: 2014 and 2015
  • Better Outcomes in Healthcare through Innovation
  • Key Findings
  • Key Findings

2. BIOSIMILARS

  • Biosimilars are Poised for Steady and Long-term Growth
  • Patenting is Largely Focused on Bio Manufacturing Capabilities
  • Production Process and Technical Needs are Complex
  • Pharma Companies Have a Strong Hold on Biosimilars Industry
  • European Regulatory Legislations Most Convenient for Developers
  • Europe Leads with the Highest Number of Approved Biosimilars
  • Key Questions for Strategy Planning

3. CANCER SCREENING

  • Early Detection and Better Treatments Possible due to Cancer Screening
  • United States Leads in Cancer Screening Innovations
  • Increase in Funding for Liquid Biopsy
  • Next-generation Sequencing is a Major Enabling Technology
  • Novel Screening Techniques will have an Impact across the Healthcare Value Chain
  • Higher Adoption Rates Witnessed in Developed Economies
  • Key Questions for Strategy Planning

4. MOLECULAR SCISSORS

  • Agbio, Human Therapeutics, R&D, and Industrial Applications Impacted by Molecular Scissors
  • Nucleases Used in Genome Editing have Varying Technical Capabilities
  • Steady Growth in Patent Filing Related to Genome Editing
  • CRISPR Patent Battle will Impact the Gene Editing Market
  • High Series Funding from Venture Capitals for Genome Editing Innovators
  • Human Therapeutics is a Key Application Area
  • North America and Europe are Dominating the Market
  • Key Questions for Strategy Planning

5. NEXT-GEN STEM CELL

  • Success in Next-Gen Stem Cells Demands Impeccable Interaction among Stakeholders
  • Clinical Trials and Stem Cell Banking Services Are Spectacularly Driving the Market
  • The Advent of Cell Reprogramming Has Reshaped IP Landscape
  • Strong Governmental Support and International Collaboration is Driving Opportunities
  • Next-Gen Stem Cell Technology is Impacting the Industry at All Decision Levels
  • Every Region is Geared toward Innovation and Commercialization
  • Clinical Translation is a Major Concern for All Science Driven Establishments
  • Key Questions for Strategy Planning

6. THERAPEUTIC ANTIBODIES

  • Therapeutic Antibodies Paving the Way for the Precision Medicine Era
  • An Unprecedented Search for Access to the Latest Advances in Monoclonal Antibodies
  • Patents of Top 3 Patent Holders Constitute One-Third of Total Published Patents
  • Private Investors and Funding Organizations Heavily Focused on Antibody Therapy
  • Immuno-oncology Leading Principal Deals in Antibody Therapeutics
  • Unprecedented Race to Reach the Top Spot in the Market
  • Strong Focus on Clinical Translation Evidenced through Creation of Companies
  • Key Questions for Strategy Planning

7. 3D SCAFFOLDS

  • 3D Scaffolds a Major Driver for the Growth of 3D Cell Culture Tools
  • US Leads 3D Scaffolds Innovation Landscape with Most Patent Applications
  • NIAMS is a Major Funding Proponent for Development
  • Functional Characteristics of 3D Scaffolds Impact Tissue Engineering
  • Key Stakeholders are Focusing on the Potential Their Products Have for In Vitro Laboratory Applications
  • Europe Leads All Regions with Highest Adoption of 3D Cell Culture Systems
  • Key Questions for Strategy Planning

8. CANCER IMMUNOTHERAPY

  • Cancer immunotherapies riding the PD-1 wave
  • European and Asian companies lead the innovation landscape
  • Moderna Therapeutics leads the venture landscape
  • Most cancer immunotherapies target immune checkpoint regulators
  • Lung cancer is a major application area for cancer immunotherapy
  • The United States and Europe lead cancer immunotherapy markets
  • Key Questions for Strategy Planning

9. HIGH-THROUGHPUT GENE SEQUENCING(HTGS)

  • Advances in HTGS driven by the race to develop low-priced platforms
  • China leads the HTGS innovation landscape
  • Cancer is a clinical hot spot for HTGS-related funding activities
  • Technology capabilities and affordability fuel sequencing innovations
  • HTGS may have increased diagnostic applications in the future
  • The United States leads the HTGS markets
  • Key Questions for Strategy Planning

10. TRANSDERMAL DRUG DELIVERY

  • Transdermal drug delivery system technology evolution
  • Translation to medical practice driving principal innovations
  • Technological trends highly reflected in patent analysis
  • Strong commitment of both public and private sources
  • Microneedles leading the technological space
  • Worldwide concerns about disorders drive developments in transdermal drug delivery
  • Companies focused on solutions in clinical practice
  • Companies focused on solutions in clinical practice
  • Companies focused on solutions in clinical practice
  • Key Questions for Strategy Planning

11. NANOMEDICINE

  • Smart nanotechnology enabling next-gen healthcare solutions
  • More than six hundred nanomedicines in clinical development
  • Top-tier companies own a pipeline of breakthrough nanotherapeutics
  • Governments have been aware of the potential of nanomedicine for nearly two decades
  • Nanomedicine and nanobiotechnology evolution as a proof of technology synergy
  • Nanomedicine evolution from nanostructures to precision therapeutic vehicles
  • Nanomedicine shifting business models for global success
  • Top-tier pharmaceutical companies' products reaching the market
  • Key Questions for Strategy Planning

12. THE FROST & SULLIVAN STORY

  • The Frost & Sullivan Story
  • Value Proposition: Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360° Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy
Back to Top